Search

Your search keyword '"DI SALVO, M"' showing total 195 results

Search Constraints

Start Over You searched for: Author "DI SALVO, M" Remove constraint Author: "DI SALVO, M"
195 results on '"DI SALVO, M"'

Search Results

151. Mitochondrial ribosomal proteins involved in tellurite resistance in yeast Saccharomyces cerevisiae.

152. Characterization of two Pantoea strains isolated from extra-virgin olive oil.

153. Stimulatory Effects of Methyl-β-cyclodextrin on Spiramycin Production and Physical-Chemical Characterization of Nonhost@Guest Complexes.

154. G4PromFinder: an algorithm for predicting transcription promoters in GC-rich bacterial genomes based on AT-rich elements and G-quadruplex motifs.

155. Bacterial bioluminescence onset and quenching: a dynamical model for a quorum sensing -mediated property.

156. A large Italian observational multicentre study on vascular ulcers of the lower limbs (Studio Ulcere Vascolari).

157. New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: a note of caution on reliance to compliance charts and nominal length.

158. Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.

159. Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies.

160. Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.

161. Prevalence of renal artery stenosis in patients undergoing cardiac catheterization.

162. Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient.

163. Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes.

164. Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation.

165. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.

166. Conformal radiotherapy of clinically localized prostate cancer: analysis of rectal and urinary toxicity and correlation with dose-volume parameters.

167. Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.

168. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.

169. Activity profile of elite goalkeepers during football match-play.

170. Proteases and chronic leg ulcers.

171. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma.

172. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.

173. Occurrence of Listeria monocytogenes in green table olives.

174. Treponema denticola cystalysin exhibits significant alanine racemase activity accompanied by transamination: mechanistic implications.

176. l-Threonine aldolase, serine hydroxymethyltransferase and fungal alanine racemase. A subgroup of strictly related enzymes specialized for different functions.

177. Distribution of B6 vitamers in Escherichia coli as determined by enzymatic assay.

178. X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with pyridoxal 5'-phosphate at 2.0 A resolution.

179. Enzymatic determination of homocysteine in cell extracts.

180. X-ray structure of Escherichia coli pyridoxine 5'-phosphate oxidase complexed with FMN at 1.8 A resolution.

181. Plasma levels of E-selectin in normolipemic and hyperlipemic arteriopathic patients after vasoactive and lipid-lowering treatment.

182. Structure of human erythrocyte catalase.

183. Deamidation of asparagine residues in a recombinant serine hydroxymethyltransferase.

184. Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy.

185. Nitrite plasma levels in normolipemic and hypercholesterolemic arteriopathics after vasoactive and lipid-lowering treatment.

186. Crystallization and preliminary X-ray crystallographic analysis of pyridoxine 5'-phosphate oxidase complexed with flavin mononucleotide.

187. Plasma levels of E-selectin in normolipemic and hyperlipemic arteriopathic patients.

188. The structure of serine hydroxymethyltransferase as modeled by homology and validated by site-directed mutagenesis.

189. Expression, purification, and characterization of recombinant Escherichia coli pyridoxine 5'-phosphate oxidase.

190. Purification and characterization of recombinant rabbit cytosolic serine hydroxymethyltransferase.

191. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].

192. Expression, purification, and characterization of human cytosolic serine hydroxymethyltransferase.

193. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.

194. Comparison of muzolimine and furosemide in heart failure.

195. [Atenolol in the treatment of arterial hypertension: clinical study].

Catalog

Books, media, physical & digital resources